Overwater, Iris E
Swenker, Rob
van der Ende, Emma L
Hanemaayer, Kimberley BM
Hoogeveen-Westerveld, Marianne
van Eeghen, Agnies M
Lequin, Maarten H
van den Ouweland, Ans MW
Moll, Henriƫtte A
Nellist, Mark
de Wit, Marie-Claire Y
Article History
Received: 13 January 2016
Revised: 4 June 2016
Accepted: 14 June 2016
First Online: 13 July 2016
Competing interests
: R Swenker reports financial assistance from Novartis. MCY de Wit reports grants from Dutch Epilepsy Foundation, and grants and non-financial support from Novartis outside the submitted work; and the Erasmus MC received honoraria from Novartis for educational lectures presented by the author. The remaining authors declare no conflict of interest.